ICCM vs. DRTS, ELMD, ZYXI, INGN, NYXH, RCEL, CATX, PROF, AVR, and OBIO
Should you be buying IceCure Medical stock or one of its competitors? The main competitors of IceCure Medical include Alpha Tau Medical (DRTS), Electromed (ELMD), Zynex (ZYXI), Inogen (INGN), Nyxoah (NYXH), AVITA Medical (RCEL), Perspective Therapeutics (CATX), Profound Medical (PROF), Anteris Technologies Global (AVR), and Orchestra BioMed (OBIO). These companies are all part of the "medical equipment" industry.
IceCure Medical vs.
Alpha Tau Medical (NASDAQ:DRTS) and IceCure Medical (NASDAQ:ICCM) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, community ranking, earnings, media sentiment, profitability, analyst recommendations, institutional ownership, valuation and dividends.
In the previous week, Alpha Tau Medical had 1 more articles in the media than IceCure Medical. MarketBeat recorded 1 mentions for Alpha Tau Medical and 0 mentions for IceCure Medical. IceCure Medical's average media sentiment score of 0.55 beat Alpha Tau Medical's score of 0.47 indicating that IceCure Medical is being referred to more favorably in the news media.
IceCure Medical received 6 more outperform votes than Alpha Tau Medical when rated by MarketBeat users. Likewise, 96.15% of users gave IceCure Medical an outperform vote while only 70.37% of users gave Alpha Tau Medical an outperform vote.
Alpha Tau Medical has a net margin of 0.00% compared to IceCure Medical's net margin of -376.85%. Alpha Tau Medical's return on equity of -38.62% beat IceCure Medical's return on equity.
2.7% of Alpha Tau Medical shares are held by institutional investors. Comparatively, 0.6% of IceCure Medical shares are held by institutional investors. 39.5% of Alpha Tau Medical shares are held by insiders. Comparatively, 2.4% of IceCure Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
IceCure Medical has higher revenue and earnings than Alpha Tau Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than IceCure Medical, indicating that it is currently the more affordable of the two stocks.
Alpha Tau Medical has a beta of 0.8, indicating that its share price is 20% less volatile than the S&P 500. Comparatively, IceCure Medical has a beta of 0.37, indicating that its share price is 63% less volatile than the S&P 500.
Alpha Tau Medical presently has a consensus price target of $8.00, indicating a potential upside of 104.60%. IceCure Medical has a consensus price target of $2.70, indicating a potential upside of 121.31%. Given IceCure Medical's stronger consensus rating and higher probable upside, analysts plainly believe IceCure Medical is more favorable than Alpha Tau Medical.
Summary
IceCure Medical beats Alpha Tau Medical on 10 of the 18 factors compared between the two stocks.
Get IceCure Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for ICCM and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
IceCure Medical Competitors List
Related Companies and Tools
This page (NASDAQ:ICCM) was last updated on 1/20/2025 by MarketBeat.com Staff
